If MRI Software has asked to talk about buying your company, you are dealing with a buyer that has made acquisitions its main route to growth in property software. Founded in 1971 and based in Solon, Ohio, MRI is owned by TA Associates, GI Partners and Harvest Partners, and its own releases announce 52 acquisitions from 2015 to 2025, in nine countries on five continents.
The buying built the business: MRI reported revenue of about $330M and EBITDA of $155M for 2019, and Reuters put revenue at close to $1bn and EBITDA at about $400M in September 2025, when its owners were exploring a sale or a listing at a value of up to $10bn including debt. In this post we look at what MRI buys, where, what it pays, how it structures a deal and what happens to a business once it joins.
Volume, criteria and terms come from MRI’s releases, the accounts of its UK group at Companies House, and the documents published for the listed companies and business lines it bought. The multiples combine those prices with the targets’ own filings.
In our view MRI is a dependable buyer that pays close to the market on revenue. Its price suits the owner of a business with thin margins and a large recurring client base best, and a second bid is the way to test it.
MRI Software Subsidiaries and Brands: How MRI Is Organized
MRI sells software to the people who own, manage, lease and occupy real estate: more than 45,000 clients in more than 170 countries, by its own count, with over 400 technology partners connected to its platform. Its products run in a few lines. The residential line covers apartment communities, residential agencies, strata managers and public and social housing. The commercial line serves landlords, investors and facilities teams. A third line serves corporate occupiers with lease accounting and workplace software, and since 2024 a small unit sells software to container lessors and depots.
John Ensign, President and Chief Administrative Officer, oversees finance, legal, operations and mergers and acquisitions, and MRI’s leadership page credits him, at MRI since 2010, with its inorganic growth strategy. Patrick Ghilani has been chief executive since 2014, a period in which MRI says revenue rose tenfold. Regional heads speak for the deals in their markets, in Asia-Pacific and in Africa.
In the UK, MRI Software Ltd consolidates the companies MRI has bought there since 2017, and its accounts at Companies House give the price of each one.
How Much MRI Software Buys
MRI’s pace came in a wave. It announced one acquisition in 2015 and two in 2016, then 43 in the six years from 2017 to 2022, with seven in 2017 and eight in each of 2019, 2020 and 2021. Its releases kept count as it went: seven companies over 2017, and eight in 2020 by the end of October. In April 2020 MRI stated that it had completed 24 acquisitions in the previous three years; its releases name 22 for that period, so the published count is a floor. From 2023 to 2025 the number fell to six, and the largest disclosed price of the decade came in 2024.
The owners changed as the buying grew. GI Partners bought MRI from Vista Equity Partners in June 2015, TA Associates invested in June 2017, and Harvest Partners joined in early 2020, with TA investing again at the same time. Ghilani said then that the new capital would allow for strategic add-on acquisitions. MRI’s bankers are Golub Capital, and its UK companies guarantee the group’s borrowings.
The 15 acquisitions with a published price add up to about $1.06bn. Our deal database holds 45 of the 52, so every breakdown on this page rests on MRI’s releases and on the filings behind each deal.
What Size of Company MRI Software Buys
MRI buys across a wide range of sizes. The 15 acquisitions with a price on record run from about $2M to $262M, with a median of about $58M and a middle half between about $23M and $103M. Four cost $100M or more, and two cost below $5M.
That set leans large, since prices become public through UK filings, listed targets and listed sellers, and 12 of the 15 are UK companies. Most of the 52 were private businesses whose prices stayed private, and several releases describe the target by a client base of a few hundred or a single home state, so the typical purchase is smaller than the median above. MRI describes its targets by clients, units or square footage managed, and its releases leave revenue unstated. For an owner, the range matters more than the median: MRI has bought regional products with a few hundred clients, business lines carved out of listed groups and three listed companies.
What MRI Software Buys
MRI buys software for one industry, real estate, across homes, offices, shops, public housing and corporate workplaces. We classified the 52 acquisitions by the market each target serves:
| Segment | Akquisitionen |
|---|---|
| Residential, agency and renter services | 21 |
| Commercial property, investment and facilities | 11 |
| Public, social and affordable housing | 10 |
| Corporate occupiers, lease accounting and workplace | 9 |
| Intermodal | 1 |
| Gesamt | 52 |
Residential leads: MRI has bought software for apartment communities, residential agents and strata managers, and the services that sit around a lease: resident screening, identity checks, rent payments, renter insurance and lease guarantees. In South Africa it bought a credit bureau for landlords. Seven of the 52 are services, insurance or data businesses, and 45 are software.
MRI has built its public and social housing business deal by deal. It bought five providers of software for US public and affordable housing from 2017 to 2020, then three UK social housing specialists in 2020, and in 2024 it bought Capita One, the public sector software business of Capita plc, which sells to UK councils and housing providers.
The occupier line came together from 2017 to 2023: MRI bought lease administration and lease accounting software in the US, Australia and the UK, workplace and visitor management software from New Zealand, and LEVERTON, a German specialist in reading leases with artificial intelligence.
MRI buys businesses that already sit in its clients’ workflow. Several targets were members of its partner program, integrated partners or suppliers to shared clients before MRI bought them. It also opens a niche when the fit is close: in 2024 it bought an Indian provider of software for container lessors and depots.
Where MRI Software Buys
MRI buys worldwide. By country, the United States leads with 21 of the 52 acquisitions, followed by the United Kingdom with 12, Australia with six, and Canada, South Africa and New Zealand with three each; Germany, India and Singapore have one each. By region, North America accounts for 24, Europe for 13, Asia-Pacific for 11 and Africa for three. One release leaves the target’s country unstated.
The mix has turned toward Asia-Pacific over the decade. From 2015 to 2019 MRI made one acquisition in the region out of 24; from 2020 to 2025 it made ten out of 28, including two listed companies, in Australia and Singapore. Of the twelve acquisitions announced from 2022 to 2025, four were in Australia and only one in the United States. Reuters reported in 2025 that more than half of MRI’s revenue comes from outside the US.
The UK shows what a buying program builds. MRI’s UK group turned over £11M in 2017 and £226M in 2025, about 20 times more, through twelve UK acquisitions and their growth after joining, and it earned EBITDA of £62.5M in 2025. MRI added offices in Singapore, the Philippines, South Africa, Canada and Saudi Arabia in 2025, and it has served the Middle East from Dubai since 2002.
What MRI Software Pays: Acquisition Multiples
MRI keeps its price range private, so its multiples come from the deals where both the price and the target’s revenue are on record. We matched the consideration in the accounts of MRI’s UK group with the targets’ own last accounts before closing, and added the listed companies and business lines MRI bought, where the offer documents and the sellers’ releases give both figures.
That gives ten acquisitions with an EV/Revenue multiple, at a median of 3.6x. Across the private software deals in our valuation research the median is 3.7x, so on revenue MRI pays close to the market. Eight of the ten sit between 2.4x and 4.2x, one sits at 4.6x and one outlier, priced on annualized figures, sits above 10x. Ten deals is a small sample, so we give the median only.
By type of seller, the five private companies in the set, all in the UK, sold at a median of 3.0x revenue. The three listed takeovers ranged from 2.4x to 4.6x, and MRI paid premiums of 43 percent to 175 percent over the prior share price. The two carve-outs from listed groups are the remaining pair, and the outlier is one of them.
Five of the ten also carry an EBITDA figure, on mixed definitions: statutory, reported and adjusted. Their median is about 25x, against 19.0x across private software deals, in a range from 9.5x to about 60x, so treat the figure as a direction on a small sample. The spread comes from margin: the three UK private companies with an EBITDA figure earned margins of 7 to 17 percent before the sale, so a price in line with the market on revenue looks expensive on profit, and MRI’s price follows revenue.
As arithmetic, 3.6x revenue equals 18x EBITDA at a 20 percent margin, 12x at 30 percent and 9x at 40 percent. MRI’s own margin is near the top of that range: about 47 percent in 2019 and about 40 percent in 2025 on the figures above. A business with a 40 percent margin bought at 3.6x revenue earns back its price in about nine years of its own EBITDA. For an owner with high margins, the revenue multiple is the one to watch; for an owner with thin margins, MRI’s pricing on revenue works in the owner’s favor.
Have an offer from MRI Software?
If MRI has sent you an offer, talk to us before you answer it. MRI is a great buyer: experienced, well funded, paying most of the price in cash at closing and able to close a listed takeover in a few months. It pays close to the market on revenue, a median 3.6x on the deals we can price against 3.7x across private software deals, and a median 3.0x for the private companies among them. Our job is to find the buyers who pay more, a strategic acquirer or a private equity platform that values your business for what it can become, and to put their bids next to MRI’s. Call us before you sign a letter of intent.
How MRI Software Structures a Deal
MRI buys whole companies. The business combinations in the accounts of its UK group from 2017 to 2022 record share purchases of 100 percent, apart from Engage Property Technology, where MRI already held 20 percent through Qube and bought the remaining 80 percent in 2019.
Payment is cash, with a fixed amount held back. In nine of the ten UK private deals with a published split, between 7 and 14 percent of the price was deferred, with a median of about 10 percent; the tenth was paid in full at closing. Where the accounts describe the timing, the holdback was payable twelve months after the acquisition. The notes list each deferred amount as a fixed figure, and small amounts went to option holders and holders of management growth shares. Acquisition costs were borne by MRI Software LLC, the US parent.
For listed companies MRI uses a scheme of arrangement, all in cash. It took Castleton Technology off AIM in 2020, PropTech Group off the ASX in early 2023 and Anacle Systems off the Hong Kong exchange in 2025, with timetables from announcement to completion of seven weeks to four months. For carve-outs it buys a business line from a listed parent: it bought Capita One on a cash-free, debt-free basis, paid a deposit at signing, and closed about eight weeks later, once Capita’s shareholders and the UK’s national security review had cleared the sale.
MRI’s president oversees these deals, with outside advisors such as Kirkland & Ellis, and MRI said in 2020 that at any point in time it is typically evaluating several opportunities across North America, the UK and Europe, and Asia-Pacific.
A holdback puts the weight on the fixed terms: its size, what it can be set against, when it is released and the warranties behind it belong in the negotiation alongside the headline price. A private equity platform can offer a different trade, part of the equity rolled into the platform and sold again at its exit, as our guide to Verkauf Ihres Unternehmens an ein Software-Roll-up describes.
What Happens After Closing
MRI’s releases put continuity first: release after release says the acquired business will continue to serve its clients as before. Several founders and executives stayed on in new roles: Cougar Software’s chief executive became an MRI vice president in 2015; CallMaX’s chief operating officer became managing director of MRI’s CallMaX division in 2016; Integratec kept its leadership and ran as a business unit.
MRI’s 2016 releases describe integration starting with corporate shared services, the alignment of sales and account management, and collaboration between product teams. MRI’s statement of intentions for Castleton in 2020 went further: it would keep the brand for at least twelve months and then decide on it, review corporate, technical and support functions where surplus headcount might be found, and review the product roadmap and research and development.
Over time the brand moves to MRI. Rockend’s and Palace’s products now trade as MRI Property Tree and MRI Palace, TCAM became MRI Asset Management Services in 2024, and the legal names of Qube, Orchard and Capita One changed to MRI names. MRI also reports growth after closing: a year after buying Rockend, it said the number of properties managed on the cloud residential software had risen 34 percent.
MRI keeps what it buys: our search found zero divestments from 2015 to 2025. Your product and clients stay together inside a larger platform, and over a few years the business becomes part of MRI, under its name.
MRI Software and Other Serial Buyers
MRI is a private equity owned consolidator, run as one company with product families and regional teams, a contrast with the decentralized operating groups of Constellation Software. In our ranking of software acquirers, which counts software and IT services deals only, MRI ranks eighth among serial consolidators, with 45 deals from 2015 to 2025.
Every one of its 52 acquisitions sits in real estate or next to it, so MRI comes to the table knowing your market. The same focus sets the ceiling on its price: MRI values what your product adds to its platform, and a buyer from outside property, or a private equity firm building a new platform, may see a different and larger opportunity.
Is This a Good Time to Sell to MRI Software?
MRI is buying fewer companies than at its peak, and bigger ones among them: six acquisitions from 2023 to 2025, against eight a year from 2019 to 2021, with the largest disclosed price of the decade in 2024 and two listed takeovers completed since 2023. GI Partners has owned part of MRI since 2015, and Reuters reported in September 2025 that its three owners were exploring a sale or a US listing, after inbound interest from real estate and technology companies. A new owner or a listing could change the pace in either direction, so an approach from MRI today is worth weighing against that uncertainty.
The wider software market repriced in early 2026, as AI coding agents cast doubt on parts of a sector that, in our view, was already carrying excessive valuations. In our March 2026 webinar on SaaS valuations we noted that the businesses holding up best were smaller, vertically focused and serving mission-critical workflows, and that more buyers now ask how a business is addressing AI disruption risk. MRI describes its platform as AI-first, so prepare to explain how your product uses AI and where it fits in that platform.
The case for selling is strongest for a founder with most of their wealth in one software business, who carries that risk alone. If your product is mission-critical for property managers, landlords or occupiers, your clients stay for years and most of your revenue recurs, the demand is there now, and MRI is one of several buyers for that profile. For an owner whose business is growing and who can carry the risk, keeping the company is a good option too. The latest prices are in our Software-Bewertungsmultiplikatoren Analyse.
Why You Need an M&A Advisor When MRI Software Approaches You
The buyer has closed 52 acquisitions in eleven years, three of them takeovers of listed companies, with a president who has spearheaded the program; the owner across the table is selling one business.
MRI makes the route in straightforward: cash at closing, a holdback of around a tenth of the price, a share purchase of the whole company and a team that has run the process many times. Speed and familiarity favor the side that has done it before. The strongest way to use an approach is as part of a process, since dealing with a single buyer alone, whether it called you or you called it, leaves you to judge its number unaided.
Establish what the business is worth before the first offer arrives, from comparable transactions and from how a buyer pricing on revenue will read your recurring revenue, your client retention and your margin. A business with high margins is the one most at risk of being priced on revenue alone.
Bring in one or two other buyers, at least one with a different model: a strategic buyer in your segment can pay for what your product adds to its own, and a private equity platform for what the business can become. The second bid tests the first, and together they give you a choice of owner for the years after closing.
Negotiate the terms as hard as the price: the size and release of the holdback, the warranties, your role afterwards and the future of your brand. A competing bid gives you room on all four. The figures on this page describe a market; your company will be priced in a negotiation.
That is the work we do for owners of software businesses while they keep running the company, and running it well through the process matters, because how the business performs ends up in the price. For how an approach fits into a wider sale, see Software-Unternehmen verkaufen und strategische versus finanzielle Käufer.
Über Aventis Advisors
Aventis Advisors is an M&A advisor for software and technology companies. We believe the world would be better off with fewer but better quality M&A deals, done at the right moment for the company and its owners. Our goal is to provide honest, insight-driven advice that lays out all the options clearly, including the option to keep the status quo.
Kontakt aufnehmen um zu besprechen, wie viel Ihr Unternehmen wert sein könnte und wie der Prozess abläuft.
